financetom
Business
financetom
/
Business
/
United States Steel Investor Ancora Files Proxy Nomination for 9 Directors, Outlines Plan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United States Steel Investor Ancora Files Proxy Nomination for 9 Directors, Outlines Plan
Apr 7, 2025 6:34 AM

09:09 AM EDT, 04/07/2025 (MT Newswires) -- United States Steel ( X ) investor Ancora said Monday that it filed a proxy statement to nominate nine directors to US Steel's board and proposed a plan to support shareholder value ahead of the company's annual meeting on May 6.

The investment management firm said its nominees would support the proposed $55-per-share sale to Nippon Steel, and stop related lawsuits.

If the deal falls through, Ancora's plan includes selling the Big River Steel unit for about $8 billion, returning $5 billion to shareholders through a special dividend, and investing the rest of the proceeds into US Steel's flat-rolled segment, Ancora said.

The proposal also includes improving union relations, reducing debt, and initiating regular dividends and share repurchases, the investor added.

United States Steel ( X ) did not immediately respond to MT Newswires' request for comment.

Shares of the company were down 1% in recent Monday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Gainers
Top Premarket Gainers
Mar 25, 2024
07:50 AM EDT, 03/25/2024 (MT Newswires) -- MicroAlgo ( VENAF ) stock rose 52% in recent Monday premarket activity, recovering from moderate losses on Friday. Salarius Pharmaceuticals ( SLRX ) shares surged 24% after reporting Friday a narrower Q4 net loss from a year earlier. Esperion Therapeutics ( ESPR ) shares rose 20% after it said Friday that the Food...
Atlassian Insider Sold Shares Worth $1,588,327, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,588,327, According to a Recent SEC Filing
Mar 25, 2024
07:26 AM EDT, 03/25/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, Co-CEO, Co-Founder, on March 22, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,588,327. Following the Form 4 filing with the SEC, Farquhar has control over a total of 32,964 shares of the company, with 32,964 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024002965/xslF345X03/primarydocument.xml Price: 191.74, Change: -0.79,...
United Reportedly Faces Possible FAA Constraints on Routes, Passengers, Pilots Over Safety Concerns
United Reportedly Faces Possible FAA Constraints on Routes, Passengers, Pilots Over Safety Concerns
Mar 25, 2024
07:42 AM EDT, 03/25/2024 (MT Newswires) -- United Airlines (UAL) may face increased scrutiny by regulators worried about recent safety lapses, news outlets reported Monday, citing unnamed sources. The Federal Aviation Administration is discussing the possibility of blocking the airline from adding new routes and barred from seating customers on its new aircraft, Bloomberg cited sources as saying. The aviation...
Novo Nordisk to Acquire Cardior Pharmaceuticals for up to $1.11 Billion
Novo Nordisk to Acquire Cardior Pharmaceuticals for up to $1.11 Billion
Mar 25, 2024
07:12 AM EDT, 03/25/2024 (MT Newswires) -- Novo Nordisk ( NVO ) said Monday it has agreed to buy Cardior Pharmaceuticals for up to about 1.03 billion euros ($1.11 billion) to support its strategy to establish a presence in cardiovascular disease. The company said the acquisition will include Cardior's lead compound CDR132L, which is currently in phase 2 clinical development...
Copyright 2023-2025 - www.financetom.com All Rights Reserved